← Leaderboards
David L Roman
University Of Michigan At Ann Arbor
$2,842,817
Attributed
$4,274,738
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $857.3K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,274,738 · 7
By mechanism
T32$1,598,519 · 1
R01$888,495 · 1
R33$822,390 · 1
R61$442,933 · 1
R21$427,625 · 1
F32$94,772 · 1
Top collaborators
- Val J Watts5 shared
- Stefan Strack4 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Kelly Bosse$65,106
- Juanita L Merchant$22,602,061
- John A Williams$14,900,884
- Chung Owyang$27,905,956
- Victor C Yang$6,066,628
Others in their field
Top investigators on “High Throughput Screening”
- Richard A Gibbs · Baylor College Of Medicine$250,166,309
- Leonard Freedman · Leidos Biomedical Research, Inc.$249,633,249
- David Heimbrook · Leidos Biomedical Research, Inc.$181,270,700
- Peter B. Gilbert · Fred Hutchinson Cancer Center$146,111,713
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
Research focus
High Throughput ScreeningCellsScreeningPharmaceutical ChemistrySignal TransductionPhenotypeSmall MoleculeProtein Protein InteractionCell PhysiologyBiochemicalLibrariesPre-ClinicalPharmacologyDesignBaseMediatingTissuesAdenylate CyclaseGtp-Binding ProteinsLinkPharmaceutical PreparationsCellular AssayNew Therapeutic TargetPathway Interactions
Grant awards (18)
Predoctoral Training in the Pharmacological Sciences$398,751
T32 · FY2025 · GM
Investigating environmental contaminant interactions on the GPCRome: an unexplored landscape of activity$233,250
R21 · FY2025 · ES · contact PI
Predoctoral Training in the Pharmacological Sciences$414,269
T32 · FY2024 · GM
Investigating environmental contaminant interactions on the GPCRome: an unexplored landscape of activity$194,375
R21 · FY2024 · ES · contact PI
Predoctoral Training in the Pharmacological Sciences$397,328
T32 · FY2023 · GM
High Throughput Screening$2
P30 · FY2023 · CA · contact PI
Non-Opioids for Inflammatory Pain: Adenylyl Cyclase 1 as a Novel Target$409,008
R33 · FY2022 · NS · contact PI
Predoctoral Training in the Pharmacological Sciences$388,171
T32 · FY2022 · GM
Non-Opioids for Inflammatory Pain: Adenylyl Cyclase 1 as a Novel Target$60,140
R33 · FY2022 · NS · contact PI
High Throughput Screening$2
P30 · FY2022 · CA · contact PI
Non-opioids for inflammatory pain: Adenylyl cyclase 1 as a novel target$353,242
R33 · FY2021 · NS · contact PI
Non-opioids for inflammatory pain: Adenylyl cyclase 1 as a novel target$400,720
R61 · FY2019 · NS · contact PI
Non-opioids for inflammatory pain: Adenylyl cyclase 1 as a novel target$42,213
R61 · FY2019 · NS · contact PI
Biochemical and Cell-Based HTS Assays for RGS17 Inhibitors$303,925
R01 · FY2014 · CA · contact PI
Biochemical and Cell-Based HTS Assays for RGS17 Inhibitors$294,526
R01 · FY2013 · CA · contact PI
Biochemical and Cell-Based HTS Assays for RGS17 Inhibitors$290,044
R01 · FY2012 · CA · contact PI
HTS for Small Molecule Modulators of RGS Proteins$48,796
F32 · FY2007 · GM · contact PI
HTS for Small Molecule Modulators of RGS Proteins$45,976
F32 · FY2006 · GM · contact PI